Semax

What is Semax?

Semax is a synthetic nootropic peptide developed in the 1980s at the Institute of Molecular Genetics of the Russian Academy of Sciences. It is a modified fragment of the adrenocorticotropic hormone (ACTH), created in such a way that it preserves its neurotrophic and protective properties without exerting a significant effect on the hormonal system.

Semax belongs to the group of nootropic peptides and is distinguished by its broad impact on brain function, cognitive processes, and neuroprotection. One of its key mechanisms is stimulating BDNF (Brain-Derived Neurotrophic Factor), which plays a central role in the growth, survival, and adaptation of neurons.

In addition, the peptide affects the dopaminergic and serotonergic systems, which explains its effects on concentration, motivation, and mood. Semax is considered one of the most studied nootropic peptides with proven effects on brain metabolism and neuronal plasticity.

What are the benefits of Semax?

Semax is a peptide with a wide range of effects that combines cognitive and neuroprotective actions.

• Improved cognitive function

Semax supports memory, concentration, and learning ability by influencing neurotransmitter systems and neuronal communication.

• Neuroprotective effect

The peptide protects nerve cells from oxidative stress and ischemic damage, making it valuable in research into neurodegenerative processes.

• Increased concentration and mental clarity

It is associated with improved focus, better information processing, and increased mental endurance under load.

• Stimulating BDNF and neuronal plasticity

Supports the formation of new neuronal connections and the brain’s adaptation to new information.

• Improved brain metabolism

Improves blood supply and oxygen delivery to the brain, which is key for its optimal function.

• Influence on mood and stress

Some studies indicate a potential effect on reducing anxiety and improving adaptation to stress.

Clinical trials on Semax

Semax is the subject of multiple clinical and experimental studies, mainly in Russia and Eastern Europe, focusing on neurology and cognitive functions.

In clinical observations, it has been reported that the peptide may:

• improve recovery after an ischemic stroke
• accelerate recovery of neurological functions
• improve memory and cognitive efficiency
• stimulate the synthesis of BDNF and other neurotrophic factors

In some studies, improvements in cognitive parameters are observed as early as within the first few weeks, suggesting a rapid effect on neuronal processes.

Additionally, the influence of Semax on brain hypoxia, neuroinflammation, and adaptation to stress is being investigated, positioning it as one of the most interesting peptides in the nootropic and neuroprotective category.

Proper intake and dosage of Semax within a research protocol

Semax is administered via subcutaneous injection in research settings.

Typical research doses are in the range of 300 to 600 mcg per day, with administration either once daily or divided into 1 to 2 intakes per day depending on the goals.

The duration of the protocol is most often between 2 and 4 weeks, after which a break of several weeks is taken in order to maintain sensitivity and evaluate the effect.

For more intensive cognitive protocols, a cyclical approach is used, as this allows better control over adaptation of the nervous system.

Possible side effects from Semax

Semax is considered a well-tolerated peptide, with unwanted reactions being rare and usually mild.

Most common:

• mild irritation (with nasal application)
• headache
• insomnia at higher doses

Less common:

• nervousness or increased excitability
• dryness
• slight increase in blood pressure

In most cases, these reactions are temporary and subside with adaptation or dose adjustment.

Information on this website is collected and summarised from multiple scientific studies and analyses.

It is purely for informational purposes and is not intended for diagnosing, treating, or preventing diseases.

The products offered on the site are not classified as medicines or medical devices and are suitable solely for laboratory and research purposes.